Cargando…
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
Alzheimer’s disease (AD), the most common dementia worldwide, remains without an effective treatment to this day despite intensive research conducted during the last decades. In this context, researchers have turned their attention towards the prevention of this pathology, focusing on early detectio...
Autores principales: | Schreiner, Thomas Gabriel, Popescu, Bogdan Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952218/ https://www.ncbi.nlm.nih.gov/pubmed/35330081 http://dx.doi.org/10.3390/life12030330 |
Ejemplares similares
-
The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2021) -
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2023)